Login / Signup

Management of Persistent Corneal Epithelial Defects with Human Amniotic Membrane-derived Dry Matrix.

Sundas Ejaz MaqsoodKareem ElsawahNavpreet DhillonShady SolimanMasara LaginafVaishali LodhiaDamian LakeSamer HamadaMohamed Elalfy
Published in: Clinical ophthalmology (Auckland, N.Z.) (2021)
AMDDM can be easily applied in the clinical setting and has demonstrated its efficiency as a new tool to treat persistent epithelial defects.
Keyphrases
  • endothelial cells
  • induced pluripotent stem cells
  • optical coherence tomography
  • mesenchymal stem cells
  • bone marrow